Table 1. Effect of galangin on plasma glucose and insulin in STZ-diabetic rats.
Groups | Glucose (mg/dl) | Insulin (μU/ml) |
---|---|---|
Control | 89.93 ± 4.74a | 15.62 ± 1.10a |
Control + galangin (16 mg/kg BW) | 85.11 ± 4.94a | 15.77 ± 0.91a |
Diabetic control | 281.10 ± 9.57b | 6.01 ± 0.44b |
Diabetic + galangin (4 mg/kg BW) | 179.86 ± 0.86c | 8.14 ± 0.79c |
Diabetic + galangin (8 mg/kg BW) | 117.10 ± 11.32d | 12.08 ± 1.04d |
Diabetic + galangin (16 mg/kg BW) | 140.53 ± 7.24e | 10.45 ± 1.72e |
Diabetic + glibenclamide (600 μg/kg BW) | 99.49 ± 5.18f | 14.20 ± 1.55f |
Values are given as means ± S.D. for six rats in each group.
a,b,c,d,e,fValues not sharing a common superscript differ significantly at P < 0.05. Duncan’s Multiple Range Test (DMRT).